Dietary treatment of congenital chylothorax with skimmed breast milk.
Congenital chylothorax
Skimmed breast milk
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
26 Aug 2021
26 Aug 2021
Historique:
received:
23
02
2021
accepted:
09
07
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
31
12
2021
Statut:
epublish
Résumé
Congenital chylothorax (CC) is a rare but potentially life-threatening condition in newborns. It is defined as an accumulation of chyle in the pleural cavity. The few publications regarding medical management and therapeutic dietary intervention motivated us to share our experience. Neonates diagnosed with congenital chylothorax and treated at Innsbruck Medical University Hospital between 2013 and 2020 (n = 6, gestational age: 36 3/7, 32 5/7, 36 4/7, 35 0/7, 35 4/7, 37 3/7 weeks) were eligible for this report. The cornerstones of treatment for chylothorax conventionally consist of chest tube drainage (CTD), respiratory support, dietary restriction of long-chain triglycerides (LCT) or total parenteral nutrition (TPN). In further course the introduction of a medium-chain triglyceride (MCT)-based formula followed by an overlapping switch to a formula with low LCT and high MCT, containing the essential long-chain fatty acids (LCFA), is attempted. In three patients we used fat-modified (skimmed) breast milk to provide a high protein and low fat diet and to avoid the discontinuation of breast milk. The outcome of an early introduction of LCFA in the form of skimmed breast milk after resolution of chylothorax diverse. One patient had a favourable outcome, meaning no recurrence of pleural effusion, adequate weight gain and a content mother, while another patient had a relapse of pleural effusion after the administration of skimmed milk and was therefore transitioned back to Basic F® . The CC of patient 5 was difficult due to Noonan syndrome. Two weeks after the introduction of skimmed breast milk the mother wanted to stop to express breast milk, so nutrition was changed to Basic F®. The first-line therapy of chylothorax is a combination of respiratory stabilization and dietary modification. The use of skimmed breast milk is advisable in CC and feasible by means of a simple milk defatting procedure. It offers benefits to mothers who wish to resume breast feeding after resolution of chylothorax and has proven positive effects, above all in preterm infants as optimal nutrition with protective components superior to formula feeding. However, the nutritional analysis of the skimmed milk and the correlation to a re-accumulation of pleural fluid remains a question to be answered.
Sections du résumé
BACKGROUND
BACKGROUND
Congenital chylothorax (CC) is a rare but potentially life-threatening condition in newborns. It is defined as an accumulation of chyle in the pleural cavity. The few publications regarding medical management and therapeutic dietary intervention motivated us to share our experience.
METHODS
METHODS
Neonates diagnosed with congenital chylothorax and treated at Innsbruck Medical University Hospital between 2013 and 2020 (n = 6, gestational age: 36 3/7, 32 5/7, 36 4/7, 35 0/7, 35 4/7, 37 3/7 weeks) were eligible for this report. The cornerstones of treatment for chylothorax conventionally consist of chest tube drainage (CTD), respiratory support, dietary restriction of long-chain triglycerides (LCT) or total parenteral nutrition (TPN). In further course the introduction of a medium-chain triglyceride (MCT)-based formula followed by an overlapping switch to a formula with low LCT and high MCT, containing the essential long-chain fatty acids (LCFA), is attempted. In three patients we used fat-modified (skimmed) breast milk to provide a high protein and low fat diet and to avoid the discontinuation of breast milk.
RESULTS
RESULTS
The outcome of an early introduction of LCFA in the form of skimmed breast milk after resolution of chylothorax diverse. One patient had a favourable outcome, meaning no recurrence of pleural effusion, adequate weight gain and a content mother, while another patient had a relapse of pleural effusion after the administration of skimmed milk and was therefore transitioned back to Basic F® . The CC of patient 5 was difficult due to Noonan syndrome. Two weeks after the introduction of skimmed breast milk the mother wanted to stop to express breast milk, so nutrition was changed to Basic F®.
CONCLUSION
CONCLUSIONS
The first-line therapy of chylothorax is a combination of respiratory stabilization and dietary modification. The use of skimmed breast milk is advisable in CC and feasible by means of a simple milk defatting procedure. It offers benefits to mothers who wish to resume breast feeding after resolution of chylothorax and has proven positive effects, above all in preterm infants as optimal nutrition with protective components superior to formula feeding. However, the nutritional analysis of the skimmed milk and the correlation to a re-accumulation of pleural fluid remains a question to be answered.
Identifiants
pubmed: 34446079
doi: 10.1186/s13052-021-01125-1
pii: 10.1186/s13052-021-01125-1
pmc: PMC8390271
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
175Informations de copyright
© 2021. The Author(s).
Références
JPEN J Parenter Enteral Nutr. 2016 May;40(4):543-51
pubmed: 25560680
Peptides. 1995;16(7):1321-6
pubmed: 8545259
Pediatr Crit Care Med. 2004 Jul;5(4):356-7
pubmed: 15215005
Semin Fetal Neonatal Med. 2017 Aug;22(4):234-239
pubmed: 28351595
Pediatrics. 1997 Dec;100(6):1035-9
pubmed: 9411381
Br J Surg. 1997 Jan;84(1):15-20
pubmed: 9043440
Mayo Clin Proc. 2009 Feb;84(2):129-33
pubmed: 19181646
Early Hum Dev. 2015 Nov;91(11):629-35
pubmed: 26375355
Nutr Clin Pract. 2013 Oct;28(5):599-602
pubmed: 23921298
J Paediatr Child Health. 2008 Dec;44(12):716-21
pubmed: 19077067
J Perinatol. 2007 Jul;27(7):434-6
pubmed: 17554391
Br Med J. 1978 Apr 22;1(6119):1018-20
pubmed: 638579
Acta Paediatr Scand. 1977 Jan;66(1):121-5
pubmed: 401553
J Paediatr Child Health. 2006 Jan-Feb;42(1-2):65-7
pubmed: 16487393
Am J Perinatol. 1999;16(8):415-20
pubmed: 10772201
J Pediatr Surg. 2003 Feb;38(2):251-3
pubmed: 12596116
Indian Pediatr. 2014 Feb;51(2):146-8
pubmed: 24632698
Eur J Nutr. 2008 Aug;47 Suppl 3:25-37
pubmed: 18683027
Pediatrics. 2005 Feb;115(2):496-506
pubmed: 15687461
Chest. 1999 Sep;116(3):682-7
pubmed: 10492271